Zhejiang Beta Pharma betapharma.com.cn

Beta Pharma is a Chinese biotech company focused on the development of therapies for cancer and inflammatory diseases. In 2011, the company received Chinese FDA approval for its "Class One" new drug Icotinib, a selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, for non-small cell lung cancer (NSCLC) in China. Icotinib is the first commercialized project in China's "Significant Innovative Drug Development" program. Beta Pharma is headquartered in Hangzhou, with its R&D c...Show all

Beta Pharma is a Chinese biotech company focused on the development of therapies for cancer and inflammatory diseases. In 2011, the company received Chinese FDA approval for its "Class One" new drug Icotinib, a selective epidermal growth factor recep...Show all

Company (Alive / Active)

All investors data 1 Investors

• Lilly Asia Ventures

There is no Investors data available for this company. Please select another tab.

There is no Board of Directors data available for this company. Please select another tab.

Board Members

Patents